The positron emission tomography (PET) scanners products market is expected to reach USD 1,441.5 million by 2025 and is expected to steadily grow at a CAGR of 5.3% to reach USD 2,415.9 million by 2035. In 2024, positron emission tomography (PET) scanners have generated roughly USD 1,368.9 million in revenues.
Positron Emission Tomography is a medical imaging method that provides pictures of the metabolic processes of tissue using radioactive tracers. The tracer emits positrons that interact with electrons producing detectable gamma rays by the PET scanner. Using this method, a high-resolution image may be made of internal functioning in the body.
The growth of PET applications is attributed to various causes. Growing advancement in technology has led to improved image quality produced and therefore enhanced ability to detect diseases at an early stage. This factor significantly attribute to the growth of the market.
In particular, this ought to track how effective treatment is, mainly in the field of cancer. Moreover, increase in awareness from both patients and physicians and a decline of costs of operation over time are also in favor of more PET use.
-Scanners-Market.jpg "Positron Emission Tomography (PET) Scanners Market")
From 2020 to 2024, a majority of updates regarding the use of positron emission tomography (PET) scanners were made. COVID-19, played a major role and acted as a causative element for the growing investments. Increase in demand for accurate medical imaging for detecting of illness and complications-has led to significant increase in growth of the market.
Growing interest in developing advanced radiopharmaceuticals and hybrid imaging modalities has made positron emission tomography (PET) scanners a more cost-effective and useful option. Interest in personalized medicine-such as the targeted treatment of diseases like cancer-has also fueled the use of PET in targeted diagnoses.
Increasing awareness among patients and providers, combined with greater insurance coverage for PET scans along with growing acceptance and adoption of PET technology in clinical settings during the study period anticipated the growth of the market during that period.
Explore FMI!
Book a free demo
A lot of reasons are why the use of Positron Emission Tomography (PET) scanners has increased in North America. One such reason is the advance of technology, especially the newly emerging hybrid systems of PET/CT and PET/MRI, which sharpen the diagnostic accuracy of functional and anatomical imaging as means for disease detection that makes PET even more valuable when it comes to the detection and monitoring of cancer, neurologic disorders, and cardiovascular diseases.
Increase in chronic diseases such as cancer also prompted the increased need for more sophisticated diagnostic equipment. Awareness of these machines keeps increasing among health care practitioners as another contributing factor that makes them acceptably spread throughout hospitals and imaging centers. In addition to this, government investments into health infrastructure and research grants have boosted the speed of adoption of PET technology to an all-time high by clinical practice across North America.
Improved technology offering newer possibilities, anticipates the growth of PET scanners as it aid in early diagnosis and treatment planning of the patients. These advancements creates a burgeoning need for intelligent diagnostic instruments because of the increasing prevalence of noncommunicable diseases. PET has particular importance in personalized therapeutic medicine as one modality capable of providing complex information about metabolic activity through which directed therapies can be developed, especially in oncology.
Furthermore, the public policies of many European states are instrumental in making it possible to receive sophisticated imaging equipment by enhancing reimbursement for PET scanning. Research and systems networking funds between health institutions and medical schools have also contributed to this progress. In general terms, all these factors have paved the way for PET to become one of the most relevant instruments in European medicine for accurate diagnosis and effective monitoring of diseases.
Growing investments in healthcare infrastructure in developing economies such as China, India, and Japan are significantly anticipating the growth demand for advanced medical technologies like PET scans. Moreover, growing necessity for precise diagnostic equipment, especially in the diagnosis of cancer and monitoring treatment such as PET scans anticipate the market growth. Additionally, growing burden of chronic diseases such as cancer, and cardiovascular diseases, promotes growing need of early detection and accurate diagnosis of the disease.
The other key area that adds impetus to this region in advancing PET use is personalized medicine per metabolic imaging. Thus, the opening up of the field of PET due to the recent launch of government programs and enhancement of healthcare budgets with new technology has further provided patient awareness and healthcare professionals on reimbursement policies that will further increase the utilization of PET scanners and hence drive sales in Asia Pacific.
Challenges
High Installation Cost Hindering Adoption in Low and Middle Income Countries
The high costs in purchase and operation of Positron Emission Tomography (PET) scanners are great obstacles in its favor. Such specialized equipment and infrastructure has driven up the cost of acquisition, setting up, and maintenance. The radioactive tracers injected into PET scans are also expensive to manufacture and handle, thus driving operational costs.
Therefore, it can be said that PET scanners become cost-ineffective in low-resource setups or even small healthcare setups. In most developing countries, scarcity of funds and unavailability of skilled professionals restrict the spread of PET on a better scale. Even if such machines were sponsored by wealthier hospitals in developed nations, operations are costing so much that this thereby restricts use in rural or deprived areas, causing inequitable access to advanced diagnostics and treatment planning.
Opportunities
Growing Emphasis of Healthcare Facilities towards Investment in Advanced Technologies
New opportunities for Positron Emission Tomography (PET) scanners emerge from government and healthcare organizations' investments in new medical technology. In its attempts to improve diagnostic accuracy and patient outcomes, the global healthcare community has led the effort to attract new governmental investments, particularly in developed and emerging economies, for the adoption of advanced diagnostic technologies such as PET scanners.
For instance, through government health initiatives targeting increased disease burden from cancers and cardiovascular diseases, they invest in imaging technologies. This includes direct funding for PET scanner buys and setting up supporting infrastructure, as well as providing subsidies or reimbursements for PET scanning.
On the whole, investments are aimed at expanding access to PET technology, making it increasingly common in hospitals and diagnostic centers. The pursuit serves the interests of PET scanner manufacturers as healthcare systems shift toward early disease detection and better treatment planning.
Growing Advancements in Hybrid Imaging Surges the Growth of the Market Increasing hybrid imaging systems, such as PET/CT, or computed tomography, PET/MRI, or magnetic resonance imaging, are some of the best-known features in the Positron Emission Tomography (PET) scanner market.
The combined functional and structural information enhances the accuracy of cancer, neurological, and cardiovascular disease detection and staging. PET/CT systems will bring most of their uses in oncology for identification of cancerous cells, treatment follow-up, and metastasis evaluation.
Meanwhile, the application of PET/MRI systems in neuroimaging is increasing because they house high resolution imaging and quality brain scans. They improve diagnostic performance and increase efficiency while eliminating the need for repeated scans and improving patient comfort. More accurate diagnoses can be achieved with treatment properly tailored.
Increasing Use of Radiopharmaceuticals in PET Imaging Surges Market Growth
Increasing applications of radiopharmaceuticals in PET imaging, a class of radioactive chemicals through which PET images and quantifies biological events occurring in the body. The development of new imaging agents - radiotracers created specifically for a particular disease condition - is rapidly extending the application scope of PET imaging within the clinic.
Newly developed tracers have enabled the early diagnosis, staging, and monitoring of therapy response in oncology. For example, fluorodeoxyglucose (FDG) usage is already well-documented in oncology, while some newer agents, such as PET-specific probes for prostate cancer or Alzheimer's disease, are rapidly entering public usage. This factors anticipate the growth of the market.
Integration of Machine Learning Platforms in PET Imaging
involvement of machine-learning algorithms and artificial intelligence (AI) in imaging workflows in an ongoing trend in the market. AI involves enhancing the examination of PET scans such that image interpretation, lesion detection, and metabolic activity measurement can be done automatedly.
These algorithms will manage patterns and anomalies that are difficult for human radiologists to catch in PET images, leading to fast and accurate diagnoses in difficult cases such as in cancer or neurological diseases. Besides, one great application of AI is in workflow automation, which tremendously reduces the amount of time spent processing and interpreting images.
This is especially true in high-volume environments. As with the expected development in technology, AI may very well improve the efficiency of PET scans, cut short misdiagnoses, and polish custom moisture therapies. This will be a future movement in expanding the area of clinical practice with PET scanners.
Growing Expansion of PET Imaging in Early Disease Detection and Monitoring
Anther emerging trend in the PET scanner market is the shift more towards early disease diagnosis and real-time monitoring of ongoing chronic conditions.
The capacity of PET to transform knowledge about tissue metabolic and molecular activities creates an incision for allowing very early detection of disease even before any modifications, as evident to any of the alternatively normative methods of anatomical imaging. This is going to be particularly significant in cancer cases, where survival can be enhanced significantly when diseases are detected early.
In general, PET is expected to increase using both prevention and personalized medicine with an increased focus on early detection and real-time continuous surveillance in many areas of therapy, which in turn is expected to improve patient outcomes
The market for PET scanners within different parts of the world has continuously increased through the upward demand for modern diagnostic imaging in the midst of increasing rates of cancer through advancements in technology between 2020 to 2024. During the historical period, healthcare providers were found enthusiastic about developing imaging centers for oncology, neurology, and cardiology. With PET combined with CT and MRI, image quality has improved further and, as a result, has been a market driving force.
In the future, 2025 to 2035, the tendency will be towards digital PET scanners offering images of better quality with reduced scanning time and, moreover, the growing need for PET as part of personalized medicine and theranostics, particularly in novel oncology drug development, imparts even more value to the market. Adoption occurs from the shift to value-based healthcare and early detection of disease.
Emerging economies are investing further in sophisticated imaging which further fuels this market advancement. In brief, advanced technology, broadening clinical applications, and increasing disease burden globally are expected to offer continued strong growth for PET scanners in years to come.
| Category | 2020 to 2024 Trends |
|---|---|
| Regulatory Landscape | FDA and CE mark approvals were most rigorously applied in the case of PET scanners, particularly regarding safety, efficacy, and imaging performance for oncology and neurological use. |
| Technological Advancements | Digital PET advancements are resulting in improved imaging quality, reduced scan times, and enhanced diagnostic accuracy in oncology, neurology, and cardiology. |
| Consumer Demand | Increasing demand for early yet accurate diagnoses mainly for cancer and neurodegenerative disease has favored their adoption in hospitals and imaging centers |
| Market Growth Drivers | The rising incidence of cancer, increasing interest in theranostics, and technologies integration (PET/CT) altogether contributed to market growth during the period of 2020 to 2024. |
| Sustainability | Companies worked toward development of PET systems that provide lower radiation exposure, more energy-efficient use, and lower operating expenditures. |
| Category | 2025 to 2035 Projections |
|---|---|
| Regulatory Landscape | Policies will hence be-strengthened, by 2035, towards integrating the AI-enabled diagnostic tools, real-time data exchange, and improved quality control in emerging economies to internationalize with common standards. |
| Technological Advancements | By 2035, AI-enabled image reconstruction, changes in the hybrid PET/MRI predominance, and enhanced tracer designs for improved precision for personalized diagnostics will characterize the PET scanners of the future. |
| Consumer Demand | Adaptation rates for PET scanners will depend on the rising chronic disease prevalence, individualized treatment planning, and increasing requirements for outpatient imaging. |
| Market Growth Drivers | The market will expand its applications into neurology and cardiology, develop new radiotracers, and increase healthcare funding in developing economies. |
| Sustainability | The paradigm of scanners will change into the more sustainable design, improved tracer lifecycle anagement, and use of energy-efficient technologies that would impact cost and the environmental footprint. |
Market Outlook
Increasing cancer cases, and fast-paced technological advances favor the market for PET scanners in the USA Increased applications of PET imaging for the diagnoses of Alzheimer's, robust reimbursement policies, and increasing demand for precision diagnostics, along with an enhanced AI integration, will further amp up the diagnostic capability.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 3.8% |
Market Outlook
The market for PET scanners in Germany is influenced by the developed healthcare systems of the country, extensive cancer screening programs, and substantial governmental support for nuclear medicine research. Increasing applications of hybrid imaging modalities (PET/CT, PET/MRI) along with an increasing need for personalized therapy for oncology are expected to facilitate a steady growth of the markets until 2035.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Germany | 4.1% |
Market Outlook
Increasing cancer incidence, greater investments in diagnostic facilities, and the rising private healthcare sector stimulate the Indian market for PET scanners. The expansion of Tier 2 and Tier 3 cities, coupled with awareness of early disease diagnostics and acceptance, are opportunities with government initiatives aimed at providing affordable access to nuclear medicine.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| India | 5.7% |
Demand in the China PET scanner market is driven with the increasing cancer burden, far-reaching healthcare reforms, and strong investment in imaging diagnostics infrastructure. Government-sponsored projects aimed at upgrading hospitals, continued momentum for hybrid PET scanner adoption, and increased clinical trials for new radiotracers will all bolster future demand in private and public sectors.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| China | 4.8% |
Market Overview Japan's PET scanner market is characterized by its elderly population, high incidence of cancer, and a keen emphasis on precision medicine. Technological advances in PET/MRI, the growing number of joint research initiatives in molecular imaging, and government support for innovative diagnostic approaches are all likely to engender sustained demand for PET scanners over the long term. Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 5.3% |
The Full-ring PET Scanners Segment Dominate the market Owing To Their Superior Imaging Performance
A full-ring PET scanner is ideal for the market since its imaging characteristics spatial resolution, sensitivity, and speed are superior. Total data acquisition in one rotation is achieved from a full 360-degree view field. It thus becomes the gold standard in oncology, cardiology, and neurology, where precision imaging becomes crucial for diagnosis and treatment planning.
Full-ring scanners enhance hybrid imaging devices like PET/CT and PET/MRI in a manner that optimally enhances overall diagnostic accuracy; hence they find extensive applications in hospitals, research centers, and teaching institutions, further assisting in the cementation of clinical and research areas.
Cost-effectiveness, Compact Size, and Flexibility of Partial-ring PET Scanners aid it Grow at Substantial Growth Rate
Partial-ring PET scanners are having tremendous growth prospects since they are comparatively affordable, smaller in dimension, and less rigid than full-ring systems. The systems find greater appeal particularly with smaller diagnostic centers, mobile imaging centers, and outpatient clinics since there is pressure on space availability and costs. The quality of the images keeps, however, bridging the gap towards almost matching full-ring scanners in exclusivity with the advanced development of detector technology and image reconstruction algorithms.
Furthermore, increasing use of point-of-care and bedside imaging in rapidly developing countries like China and India is propelling these markets. Their capability of delivering low dose radiation and - local, targeted imaging makes them tailor-made for unique, low volume diagnosis procedures.
The Hospital Segment Dominates the Positron Emission Tomography (PET) Scanners as it act as Primary Centers For Advanced Diagnostic Imaging
The hospital segment leads the Positron Emission Tomography (PET) Scanners market since hospitals are the central points for sophisticated diagnostic imaging in oncology, cardiology, and neurology. Hospitals tend to have high patient volumes, thereby allowing full utilization of expensive full-ring PET scanners for some return on investment (ROI).
Hospitals have a greater tendency to combine PET imaging with other modalities, such as CT or MRI, to ensure a complete diagnostic workflow. And hospitals generally have well-trained radiologists and nuclear medicine specialists who will interpret complex PET scans and assert the hospital's positioning as the center for diagnostic imaging. Their ability to offer comprehensive care, from diagnosis to treatment planning, affirms their superiority.
Rising Demand for Specialized Diagnostic Services aid it to grow at a Substantial Growth Rate
Specialty diagnostic tests in developed and emerging economies are in great demand; therefore, PET centers are on a steady rise. These centers perform only PET imaging, allowing them to reduce operational complexity and keep the scanning fees lower than those in hospitals. Improvements in PET technology, with better performance in partial-ring systems, less expensive equipment, and lower infrastructure requirements, have given impetus to the development of free-standing PET centers.
The PET scanners market is a technological one; competition emanates from the approval of technology, demand for precise diagnostic imaging, demand for better resolution and faster scan times, and hybrid imaging capability (PET/CT, PET/MRI). The race has commenced, especially in the emerging markets, to manufacture small and cost-effective scanners for the outpatient and mobile applications.Strategic alliances with hospitals, diagnostic laboratories, and research centers are crucial to seize any market share. In addition, vendors are focusing on applying AI for advanced image reconstruction and workflow automation. With the emergence of specialty PET centers, competition rises as vendors strive to provide affordable and performant solutions. Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| GE Healthcare | 33.6% - 38.5% |
| Toshiba Corporation | 20.4% - 22.6% |
| Koninklijke Philips N.V. | 50.1% - 17.2% |
| Siemens Healthineers | 4.6% - 6.8% |
| Other Companies (combined) | 12.1% - 15.4% |
| Company Name | Key Company Developments and Activities |
|---|---|
| GE Healthcare | GE healthcare launched SIGNA PET/MR high capacity PET imaging coupled with MR imaging for more precise diagnosis in oncology, neurology, and cardiology and also showcased the innovative digital PET detector technology adoption as part of the strategy for improving image resolution and lowering the radiation dose. |
| Canon Medical Systems | Canon Medical, formerly Toshiba, has introduced the highly sensitive and faster scanning Cartesion Prime Digital PET/CT system to maximize patient throughput with increased productivity and lowers operational costs. The focus is on lower dose imaging solutions, which could be in line with global trends on reducing radiation doses. |
| Koninklijke Philips N.V. | Philips has announced the launch of Vereos, the world's first fully digital PET-CT scanner that improves resolution and quantitative accuracy for oncology, cardiology, and neurological examinations. Philips is going to build AI into image reconstructing to enable faster and more accurate diagnostic methods |
| Siemens Healthineers | Siemens Healthineers offers Biograph Vision Quadra, a whole body PET/CT scanner in the next generation which is especially designed to increase the axial field of view to take images in multifold and speedier ways |
Key Company Insights
GE Healthcare:
GE Healthcare is leading in hybrid PET/CT and PET/MR technologies by combining AI with molecular imaging to enhance diagnoses for cancer and neurological disorders. It is a recognized leader in the field of precision imaging technology, with an established global footprint, continued attention to R&D spending, and cooperative development of tracers.
Canon Medical Systems:
Canon Medical systems offers state-of-art patent CT solutions maintaining low doses and fast imaging. Following the principles of clinical cooperation, lowering radiation doses, and a solid customer service network, Canon integrates accurate imaging with patient safety, thereby holding a competitive edge in major global healthcare markets.
Koninklijke Philips N.V.:
Philips translates digital PET innovation into Vereos and smart workflows. Its theranostic PET offering, sustainability-related orientation, and AI-rooted imaging ensure that it operates with high levels of diagnostic precision and functionality in oncology, cardiology, and neurology imaging.
Beyond the leading companies, several other manufacturers contribute significantly to the market, enhancing product diversity and technological advancements. They include:
The overall market size for positron emission tomography (PET) scanners market was USD 1,441.5 million in 2025.
The positron emission tomography (PET) scanners market is expected to reach USD 2,415.9 million in 2035.
Increase in adoption of positron emission tomography (PET) scanners for scanning severe diseases such as cancer anticipates the growth of the market.
The top key players that drives the development of positron emission tomography (PET) scanners market are GE Healthcare, Toshiba Corporation, Koninklijke Philips N.V., Siemens Healthineers and Hitachi Medical Corporation.
Full-ring PET Scanner segment by product is expected to dominate the market during the forecast period.
Full-ring PET Scanner and Partial-ring PET Scanner
Oncology, Cardiology, Neurology and others
Bismuth Germanium Oxide, Lutetium Oxyorthosilicate, Gadolinium Oxyorthosilicate, Lutetium Fine Silicate and Lutetium Yttrium Orthosilicate
Hospitals, Diagnostic Centers, PET Centers and Research Institute
North America, Latin America, Western Europe, Eastern EurAope, East Asia, South Asia & Pacific, Middle East & Africa
Epidemic Keratoconjunctivitis Treatment Market Overview – Growth, Trends & Forecast 2025 to 2035
Eosinophilia Therapeutics Market Insights – Trends & Forecast 2025 to 2035
Endometrial Ablation Market Analysis - Size, Share & Forecast 2025 to 2035
Endotracheal Tube Market - Growth & Demand Outlook 2025 to 2035
Encephalitis Treatment Market - Growth & Future Trends 2025 to 2035
Edward’s Syndrome Treatment Market – Growth & Future Prospects 2025 to 2035
Positron Emission Tomography (PET) Scanners Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
